Sara Feola

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Journal for immunotherapy of cancer

Cancers

Nature communications

Science advances

University of Helsinki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki

Finland

Post Doc :: Faculty of Pharmacy

Publications

Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff, Gabriella Antignani, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega, Sari Pesonen, Jeanette H W Leusen, Mikaela Grönholm, Vincenzo Cerullo
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for immunotherapy of cancer 12 (3) (2024)
Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff, Gabriella Antignani, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega, Sari Pesonen, Jeanette H W Leusen, Mikaela Grönholm, Vincenzo Cerullo
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for immunotherapy of cancer 12 (3) (2024)
Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff, Gabriella Antignani, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega, Sari Pesonen, Jeanette H W Leusen, Mikaela Grönholm, Vincenzo Cerullo
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for immunotherapy of cancer 12 (3) (2024)
Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff, Gabriella Antignani, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega, Sari Pesonen, Jeanette H W Leusen, Mikaela Grönholm, Vincenzo Cerullo
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for immunotherapy of cancer 12 (3) (2024)
Lorella Tripodi, Emanuele Sasso, Sara Feola, Ludovica Coluccino, Maria Vitale, Guido Leoni, Barbara Szomolay, Lucio Pastore, Vincenzo Cerullo
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies. Cancers 15 (4) (2023)
Francesco Manfredi, Lorena Stasi, Silvia Buonanno, Francesca Marzuttini, Maddalena Noviello, Sara Mastaglio, Danilo Abbati, Alessia Potenza, Chiara Balestrieri, Beatrice Claudia Cianciotti, Elena Tassi, Sara Feola, Cristina Toffalori, Marco Punta, Zulma Irene Magnani, Barbara Camisa, Elena Tiziano, Maria Teresa Lupo-Stanghellini, Rui Mamede Branca, Janne Lehtiö, Tiina M Sikanen, Markus J Haapala, Vincenzo Cerullo, Monica Casucci, Luca Vago, Fabio Ciceri, Chiara Bonini, Eliana Ruggiero
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR. Science advances 9 (48) (2023)
Lorella Tripodi, Emanuele Sasso, Sara Feola, Ludovica Coluccino, Maria Vitale, Guido Leoni, Barbara Szomolay, Lucio Pastore, Vincenzo Cerullo
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies. Cancers 15 (4) (2023)
Jacopo Chiaro, Gabriella Antignani, Sara Feola, Michaela Feodoroff, Beatriz Martins, Hanne Cojoc, Salvatore Russo, Manlio Fusciello, Firas Hamdan, Valentina Ferrari, Daniele Ciampi, Ilkka Ilonen, Jari Räsänen, Mikko I Mäyränpää, Jukka Partanen, Satu Koskela, Jarno Honkanen, Jussi Halonen, Lukasz Kuryk, Maria Rescigno, Mikaela Grönholm, Rui Mamede Branca, Janne Lehtiö, Vincenzo Cerullo
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors. Nature communications 14 (1) (2023)
Lorella Tripodi, Emanuele Sasso, Sara Feola, Ludovica Coluccino, Maria Vitale, Guido Leoni, Barbara Szomolay, Lucio Pastore, Vincenzo Cerullo
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies. Cancers 15 (4) (2023)
Erkko O Ylösmäki, Manlio Fusciello, Beatriz Martins, Sara Feola, Firas Hamdan, Jacopo Chiaro, Leena Ylösmäki, Matthew J Vaughan, Tapani Viitala, Prasad S Kulkarni, Vincenzo Cerullo
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin. Journal for immunotherapy of cancer 9 (7) (2022)
Firas Hamdan, Erkko O Ylösmäki, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Manlio Fusciello, Sara Feola, Beatriz Martins, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Otto Kari, Moon Lee, Petrus Järvinen, Harry Nisen, Anna Kreutzman, Jeanette H W Leusen, Mohamed El Missiry, Thomas G McWilliams, Mikaela Grönholm, Vincenzo Cerullo
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids. Journal for immunotherapy of cancer 9 (8) (2022)
Federica Bellato, Sara Feola, Gloria Dalla Verde, Greta Bellio, Marco Pirazzini, Stefano Salmaso, Paolo Caliceti, Vincenzo Cerullo, Francesca Mastrotto
Mannosylated Polycations Target CD206 + Antigen-Presenting Cells and Mediate T-Cell-Specific Activation in Cancer Vaccination. Biomacromolecules (2022)
Sara Feola, Jacopo Chiaro, Beatriz Martins, Salvatore Russo, Manlio Fusciello, Erkko Ylösmäki, Chiara Bonini, Eliana Ruggiero, Firas Hamdan, Michaela Feodoroff, Gabriella Antignani, Tapani Viitala, Sari Pesonen, Mikaela Grönholm, Rui M M Branca, Janne Lehtiö, Vincenzo Cerullo
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines. eLife 11 (2022)
Jacopo Chiaro, Henna H E Kasanen, Thomas Whalley, Cristian Capasso, Mikaela Grönholm, Sara Feola, Karita Peltonen, Firas Hamdan, Micaela M Hernberg, Siru Mäkelä, Hanna Karhapää, Paul E Brown, Beatriz Martins, Manlio Fusciello, Erkko O Ylösmäki, Dario Greco, Anna S Kreutzman, Mohamed El Missiry, Barbara Szomolay, Vincenzo Cerullo
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma. Cancer immunology research 9 (8) (2021)
Sara Feola, Markus Haapala, Karita Peltonen, Cristian Capasso, Beatriz Martins, Gabriella Antignani, Antonio Federico, Vilja Pietiäinen, Jacopo Chiaro, Michaela Feodoroff, Salvatore Russo, Antti Rannikko, Manlio Fusciello, Satu Koskela, Jukka Partanen, Firas Hamdan, Sari M Tähkä, Erkko Ylösmäki, Dario Greco, Mikaela Grönholm, Tuija Kekarainen, Masoumeh Eshaghi, Olga L Gurvich, Seppo Ylä-Herttuala, Rui M M Branca, Janne Lehtiö, Tiina M Sikanen, Vincenzo Cerullo
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification. ACS nano 15 (10) (2021)
Karita Peltonen, Sara Feola, Husen M Umer, Jacopo Chiaro, Georgios Mermelekas, Erkko O Ylösmäki, Sari Pesonen, Rui M M Branca, Janne Lehtiö, Vincenzo Cerullo
Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy. Cancers 13 (14) (2021)
Sara Feola, Jacopo Chiaro, Beatriz Martins, Vincenzo Cerullo
Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process. Cancers 12 (6) (2020)
Beatrice Polini, Sara Carpi, Stefano Doccini, Valentina Citi, Alma Martelli, Sara Feola, Filippo Maria Santorelli, Vincenzo Cerullo, Antonella Romanini, Paola Nieri
Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma. International journal of molecular sciences 21 (17) (2020)
Siri Tähtinen, Sara Feola, Cristian Capasso, Netta Laustio, Christianne Groeneveldt, Erkko O Ylösmäki, Beatriz Martins, Manlio Fusciello, Marta Medeot, Maria Tagliamonte, Jacopo Chiaro, Firas Hamdan, Karita Peltonen, Tuuli Ranki, Luigi Buonaguro, Vincenzo Cerullo
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy. Cancer research 80 (12) (2020)
Manlio Fusciello, Flavia Fontana, Siri Tähtinen, Cristian Capasso, Sara Feola, Beatriz Martins, Jacopo Chiaro, Karita Peltonen, Leena Ylösmäki, Erkko Ylösmäki, Firas Hamdan, Otto K Kari, Joseph Ndika, Harri Alenius, Arto Urtti, Jouni T Hirvonen, Hélder Almeida Santos, Vincenzo Cerullo
Artificially cloaked viral nanovaccine for cancer immunotherapy. Nature communications 10 (1) (2019)

Sara Feola.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sara Feola